Aesica: Developing and commercialising pharmaceuticals globally

From the day Aesica was founded in 2004, we’ve been committed to being fast, flexible, innovative and reliable. Qualities which are helping to make us one of the world’s leading contract developers and manufacturers of pharmaceuticals. Our workforce has grown to 1300 people based globally and over the last five years we have experienced a six fold increase in turnover.

Our head office in Newcastle supports a network of manufacturing sites across Europe, including Cramlington, Nottingham and Queenborough in the UK, Monheim and Zwickau in Germany, and Pianezza in Italy. We also have a sales office over in Shanghai. Each of the manufacturing sites has state-of-the-art facilities, enabling the delivery of full manufacturing services in a growing number of markets.  The business is divided into three operational units:

The API business unit works from laboratory through to commercial scale manufacture. Its analytical expertise and ability to work in strategic partnership with clients enables the team to respond quickly and effectively to market demand.

The Formulation Development team provides market leading formulation development, analytics and GMP services and is acknowledged as the leading provider of clinical pharmaceutical dosage form development in Europe. The team guides clients through the processes of new medicine and material development for Phase I and Phase II clinical trials.

The Formulated Products business unit offers manufacturing and packaging of pharmaceutical products and has highly secure facilities authorised to handle controlled substances.

This diverse and significant experience in contract manufacturing has earned us the place as partner of choice to several of the top ten global pharmaceutical leaders, emerging life science companies and leading generic manufacturers. But we’re not ones to become complacent. The success of our business is built on a continual desire to improve and achieve outstanding results. We’re constantly developing the technical and analytical skills of our people to ensure that we’re capable of meeting the ever-changing demands of our customers.

Our vision is to become the number one supplier of Active Pharmaceutical Ingredients (API) and Formulated Products to the pharmaceutical industry, and we’ve had a remarkable eight years trying to get there. From acquisitions and rapid growth, to being listed in the 2012 Sunday Times HSBC International Track 200 (a newly created list that ranks Britain’s private companies with the fastest growing international sales) it’s these achievements that are putting us on the right track to realising our vision.

Help Tell Our Story

Share Your Story

What People Say About NewcastleGateshead

If you love where you live, tell the world: Become a NewcastleGateshead Ambassador

Why We're Great

Get Involved

Get Involved

You’ll find everything you need to know to get started right here.

News Around NewcastleGateshead